Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chafic Karam

Showing results (51-60 of 118) with videos related to

Pageof 12
Sort By:
Journal of Neurology|May 14, 2020
Screening for genetic mutations in patients with neuropathy without definite etiology is usefulBraden Vogt, Nizar Chahin, Wojciech Wiszniewski, et al.
Neurology|July 9, 2024
Mononeuropathy Due to Inflammatory Pseudotumor of NerveFelipe J S Jones, Madeline Singer, Eric Zager, et al.
Journal of Neurosurgery. Spine|April 20, 2019
Lumbar laminotomy for the intrathecal administration of nusinersen for spinal muscular atrophy: technical note and outcomesDiana Ko, Daniel Blatt, Chafic Karam, et al.
Neurorehabilitation|September 28, 2015
Comprehensive rehabilitative care across the spectrum of amyotrophic lateral sclerosisSabrina Paganoni, Chafic Karam, Nanette Joyce, et al.
Heart Failure Reviews|February 20, 2021
Screening for ATTR amyloidosis in the clinic: overlapping disorders, misdiagnosis, and multiorgan awarenessJose N Nativi-Nicolau, Chafic Karam, Sami Khella, et al.
Journal of the Neurological Sciences|August 26, 2020
Refractory CIDP: Clinical characteristics, antibodies and response to alternative treatmentJamila Godil, Matthew J Barrett, Erik Ensrud, et al.
Muscle & Nerve|July 14, 2021
Subcutaneous immunoglobulin treatment for chronic inflammatory demyelinating polyneuropathyNamita A Goyal, Chafic Karam, Kazim A Sheikh, et al.
Neurologic Clinics|October 31, 2015
Complementary and Alternative Therapies in Amyotrophic Lateral SclerosisRichard S Bedlack, Nanette Joyce, Gregory T Carter, et al.
Neurology|September 21, 2011
Clinical reasoning: a 34-year-old man with recurrent limb weaknessChafic Karam, P James B Dyck, Janean K Engelstad, et al.
Annals of Clinical and Translational Neurology|May 27, 2021
Long-term efficacy of eculizumab in refractory generalized myasthenia gravis: responder analysesJames F Howard, Chafic Karam, Marcus Yountz, et al.
Pageof 12

Showing results (51-60 of 118) with videos related to

Sort By:
Pageof 12
Journal of Neurology|May 14, 2020
Screening for genetic mutations in patients with neuropathy without definite etiology is usefulBraden Vogt, Nizar Chahin, Wojciech Wiszniewski, et al.
Neurology|July 9, 2024
Mononeuropathy Due to Inflammatory Pseudotumor of NerveFelipe J S Jones, Madeline Singer, Eric Zager, et al.
Journal of Neurosurgery. Spine|April 20, 2019
Lumbar laminotomy for the intrathecal administration of nusinersen for spinal muscular atrophy: technical note and outcomesDiana Ko, Daniel Blatt, Chafic Karam, et al.
Neurorehabilitation|September 28, 2015
Comprehensive rehabilitative care across the spectrum of amyotrophic lateral sclerosisSabrina Paganoni, Chafic Karam, Nanette Joyce, et al.
Heart Failure Reviews|February 20, 2021
Screening for ATTR amyloidosis in the clinic: overlapping disorders, misdiagnosis, and multiorgan awarenessJose N Nativi-Nicolau, Chafic Karam, Sami Khella, et al.
Journal of the Neurological Sciences|August 26, 2020
Refractory CIDP: Clinical characteristics, antibodies and response to alternative treatmentJamila Godil, Matthew J Barrett, Erik Ensrud, et al.
Muscle & Nerve|July 14, 2021
Subcutaneous immunoglobulin treatment for chronic inflammatory demyelinating polyneuropathyNamita A Goyal, Chafic Karam, Kazim A Sheikh, et al.
Neurologic Clinics|October 31, 2015
Complementary and Alternative Therapies in Amyotrophic Lateral SclerosisRichard S Bedlack, Nanette Joyce, Gregory T Carter, et al.
Neurology|September 21, 2011
Clinical reasoning: a 34-year-old man with recurrent limb weaknessChafic Karam, P James B Dyck, Janean K Engelstad, et al.
Annals of Clinical and Translational Neurology|May 27, 2021
Long-term efficacy of eculizumab in refractory generalized myasthenia gravis: responder analysesJames F Howard, Chafic Karam, Marcus Yountz, et al.
Pageof 12